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Design: Meta-analysis of three phase 3B randomized active-comparator
trials.
Methods: This meta-analysis according to Cochrane’s approach assessed
EOC using a validated nurse questionnaire (22 items grouped into three
subscales, which include time efficiency, convenience, and satisfaction)
in adult patients treated with fentanyl ITS or morphine IV PCA for post-
operative pain management. The weighted mean difference (WMD)
between treatments was calculated.
Finding:EOCanalyseswere based on responses to questionnaires from848
(fentanyl ITS) and 761 (morphine IV PCA) nurses. Fentanyl ITS was re-
ported to provide significant advantages compared with morphine IV
PCA in terms of nurses’ overall EOC (WMD 5 –0.57, P , .0001)
and each of the subscales: time efficiency (WMD520.58, P, .0001), con-
venience (WMD 5 20.57, P , .0001), and satisfaction (WMD 5 20.47,
P , .0001).
Conclusions: In this meta-analysis, fentanyl ITS is associated with a supe-
rior EOC profile from the nurses’ perspective than morphine IV PCA.
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Figure 1. Illustration of the fentanyl iontophoretic
transdermal system controller and drug unit and
assembled system. The device is approximately the
size of a credit card. The controller and drug unit
are assembled by the health care professional imme-
diately before the application. This figure is available
in color online at www.jopan.org. Reprinted with
permission from The Medicines Company (Parsip-
pany, NJ).
2 PESTANO ET ALINTRAVENOUS (IV) PATIENT-CONTROLLED
ANALGESIA (PCA) has been shown to provide
effective pain relief and become standard practice
for postoperative pain management.1-5 However,
IV PCA requires IV access, can often limit
mobility, and an associated risk of medication
and pump programming errors.6-9 Some of the
safety hazards with IV PCA include use of wrong
analgesic or concentration, accidental pump
misprograming, false triggering (eg, PCA button
short circuit), unintended dose administration by
proxy (eg, activation of PCA pump by nurse/
visitors), drug accumulation in IV dead space,
runaway fluid column because of siphoning or
other means, PCA pump malfunction because of
hardware failure or software design error,
retrograde flow of PCA analgesic into a second IV
set because of catheter blockade, and others.9 In
2009, the estimated annual error rates per
10,000 people in the United States were 407 for
IV PCA-related errors and 17 for device-related er-
rors.10 The average cost per error in this analysis
ranged between $552.00 and $773.00.10 As ex-
pected, harmful errors were much more costly
than nonharmful errors. Another concern with
traditional IV PCA is that infusion pumps may be
at risk for hacking, which could lead to modifica-
tions of doses by unauthorized users.11
Fentanyl iontophoretic transdermal system (ITS) is
a preprogrammed needle-free PCA approach for
the management of moderate-to-severe acute post-
operative pain by administering the analgesic via
iontophoresis. Iontophoresis allows transdermal
delivery of fentanyl through the skin by the appli-
cation of a low-intensity and nearly imperceptible
electric current.12 The system is pictured in
Figure 1. Staff time spent on traditional IV PCA
administration such as obtaining supplies to
initiate therapy, time required to program the
pump, a secondary nurse to confirm the order
and programming, and time to deal with malfunc-
tions and refills should be reduced with fentanyl
ITS allowing nurses more time for direct patient
care.13-21
Fentanyl ITS delivers analgesic doses based on pa-
tient control and has demonstrated to have compa-
rable efficacy to morphine IV PCA.15-18
Ease of care (EOC) for nurses is an important
parameter to measure, especially with new tech-nology such as fentanyl ITS. A validated question-
naire has been developed for evaluating EOC for
patients receiving PCA from the nurses’ perspec-
tive.22 We have previously reported results using
a simple pooled analysis of two phase 3B active-
comparator clinical trials that compared fentanyl
ITS with morphine IV PCA and used the nurses’
EOC questionnaire.23 In this article, we use a
meta-analysis that compares fentanyl ITS with
morphine IV PCA from the three phase 3B active-
comparator studies conducted in the development
of fentanyl ITS that captured EOC from the nurses’
perspective. By using a meta-analysis, we should
be able to detect treatment effects with greater po-
wer and estimate these effects with greater preci-
sion.24 A strength of this analysis is that all the
included studies were designed to reflect real-
world practice and included many different sur-
gery types. Therefore, the results of this meta-
analysis should be generalizable to many types of
patients with postoperative pain.
Methods
PubMed, Cochrane Library, and Google Scholar
were searched combining the terms fentanyl and
iontophoretic and ease of care for the period of
1980 to August 1, 2015. Studies were included if
they studied fentanyl ITS and had used the vali-
dated nurse EOC questionnaire.22 The
COMPARISON OF FENTANYL ITS VS MORPHINE IV PCA 3manufacturer also provided information regarding
their phase 3B clinical studies. One pooled analysis
that detailed the results of two studies was
included from the literature, and one study was
included from the manufacturer.23 The manufac-
turer indicated that only three studies in the clin-
ical development program had used the validated
nurse EOC questionnaire. All data relating to the
nurse EOC questionnaire were provided by the
manufacturer relating to these three studies. At
the time that themeta-analysiswas conducted, fen-
tanyl ITS was not commercially available, and
therefore, no additional studies could have been
performed. Therefore, all studies that had been
conducted with fentanyl ITS and used the vali-
dated nurse EOC questionnaire were included.
A meta-analysis was conducted using data from all
the active-comparator phase 3B studies that
compared fentanyl ITS with morphine IV PCA
and used the validated nurse EOC question-
naire.15-17 The three active-comparator, random-
ized, and multicenter studies enrolled
postoperative patients at least 18 years of age
who underwent a variety of different surgical pro-
cedures (Table 1). The methodology of these trials
has been described previously.15-17 Briefly, patients
were randomly assigned to receive either fentanyl
ITS (n 5 961) or morphine IV PCA (n 5 982)
(evaluable for efficacy population). Patients in
the fentanyl ITS group received a 40 mcg dose
over 10 minutes for up to 6 doses/hour for
24 hours or a maximum of 80 doses per system
(whichever occurred first), after which a new
system could be applied if needed. Patients
treated with morphine IV PCA received 1 mg
morphine bolus doses for up to 10 doses/hour
with a 5- or 6-minute lock-out periods between
doses (depending on site-specific policies) for
24 hours (up to a maximum of 240 doses). The
meta-analysis was conducted according to the Co-
chrane methodology.25
The nurse EOC questionnaire is a validated tool
that consists of 22 items grouped into three sub-
scales (Figure 2). Each item on the EOC question-
naire that contributed to the overall EOC was
scored on a six-point Likert scale. The subscales
for the nurse EOC questionnaire includes time effi-
ciency (measures the time consumption associ-
ated with completing patient care tasks),
convenience (measures the bothersome aspectsof completing patient care tasks), and satisfaction
(measures the satisfaction with the method of
pain control).
Items on the time-efficiency subscale were scored
with the following options: not at all time
consuming (0), a little bit time consuming (1),
somewhat time consuming (2), quite a bit time
consuming (3), a great deal time consuming (4),
and a very great deal time consuming (5). A lower
score indicated more favorable results.
The convenience subscale was scored with the
following options: not at all bothersome (0), a little
bit bothersome (1), somewhat bothersome (2),
quite a bit bothersome (3), a great deal bother-
some (4), and a very great deal bothersome (5).
A lower score indicated more favorable results.
Items on the satisfaction subscale include
response options on a six-point Likert scale with
the following options: extremely dissatisfied (0)
to extremely satisfied (5); however, for purposes
of the analyses in this article, we transformed the
satisfaction scale so that lower scores indicated
more favorable results for ease of interpretation
(ie, extremely dissatisfied was originally a 0 but
was transformed to a 5 and extremely satisfied
was a 5 but was transformed to a 0). Overall EOC
was measured using both time efficiency and con-
venience items; lower scores indicate more favor-
able results.22
Research nurses, staff nurses, and study coordina-
tors who gave primary care to patients were
eligible to complete the nurse EOC questionnaire
in all three studies. Eligible nurses completed the
validated nurse EOC questionnaire22 after the
completion of at least 10 patients or on study
completion at their respective sites. A minimum
percentage of responses (40%) was required on
the EOC questionnaire to be included in this anal-
ysis. These minimum response criteria ensured
that only those nurses who had completed at least
four different tasks directly related to patient care
with the systems were included in this analysis.
Statistical Analysis
The meta-analysis was conducted using random-
effects models.25 Analyses using random-effects
models assume that the results are to be
Table 1. Overview of Included Studies and Subject Characteristics (Evaluable for Efficacy
Population)
Hartrick et al16 Minkowitz et al17 Grond et al15
Fentanyl
ITS
Morphine
IV PCA
Fentanyl
ITS
Morphine
IV PCA
Fentanyl
ITS
Morphine
IV PCA
Location(s) United States United States Europe (Austria, Belgium, Denmark,
France, German, Italy, Ireland,
Spain, Sweden, Switzerland, and the
United Kingdom)
Number of sites 52 39 51
Surgery type Hip replacement Abdominal or pelvic Different*
Evaluable
population (n)
389 397 250 251 322 334
Sex, n (%)
Female 204 (52.4) 202 (50.9) 210 (84.0) 210 (83.7) 184 (57.1) 190 (56.9)
Male 185 (47.6) 195 (49.1) 40 (16.0) 41 (16.3) 138 (42.9) 144 (43.1)
Age (y), mean (SD) 62.8 (12.0) 62.8 (12.4) 50.3 (14.1) 50.5 (14.0) 53.4 (14.5) 53.0 (14.6)
BMI (kg/m2),
mean (SD)
29.7 (5.5) 29.2 (5.5) 29.3 (7.4) 29.7 (7.0) — —
Race, n (%)
Caucasian 356 (91.5) 365 (91.9) 185 (74.0) 185 (73.7) 305 (94.7) 322 (96.4)
Black 24 (6.2) 21 (5.3) 48 (19.2) 48 (19.1) 4 (1.2) 6 (1.8)
Asian 3 (0.8) 0 2 (0.8) 1 (0.4) 2 (0.6) 2 (0.6)
Hispanic 5 (1.3) 6 (1.5) 13 (5.2) 16 (6.4) 0 0
Other/unknown 1 (0.3) 5 (1.3) 2 (0.8) 1 (0.4) 11 (3.4) 4 (1.2)
ITS, iontophoretic transdermal system; IV, intravenous; PCA, patient-controlled analgesia; SD, standard deviation;
BMI, body mass index.
*Orthopaedic, abdominal, pelvic, and general.
4 PESTANO ET ALgeneralized to the entire patient population. The
random-effects method has been used previously
in Cochrane evaluations of this and other clinical
areas.25,26 The software used in the statistical
analysis was SAS, version 9.3.
Mean scores were calculated for each individual
item in the questionnaire and for the overall EOC
as well as the subscales (time efficiency [items 1
to 10], convenience [items 11 to 20], and satisfac-
tion [items 21 and 22]). Lower mean scores indi-
cate better responses from the nurses. Post hoc
analyses were completed evaluating responders.
A nurse responder for the overall EOC was defined
as a nurse who responded with one of the three
most positive choices on all time-efficiency and
convenience items when at least 40% of items
are responded to. A nurse responder for time effi-
ciency and convenience was defined as a nurse
who responded with one of the three most posi-
tive choices for all items in each subscale if at least40% of items are responded to for that subscale. A
nurse responder for satisfaction was defined as a
nurse who responded with one of the two most
positive choices for both satisfaction items. In
these studies, not all nurses were responsible for
all tasks; therefore, it was anticipated that nurses
would not respond to some items on the nurse
EOC questionnaire. Therefore, a minimum per-
centage of responses (40%) was required for a
questionnaire to be included in the analysis. This
minimum response requirement ensured that
only those who had completed at least four
different tasks directly related to patient care
with PCA devices for each subscale were included.
The percentage of nurses who favored each PCA
modality was calculated for the nurses who evalu-
ated both fentanyl ITS and morphine IV PCA’. A
nurse who had a lower mean score on a given sub-
scale for patients who received fentanyl ITS
compared with patients who received morphine
Figure 2. Nurse ease-of-care questionnaire. Adapted from Ref. 22
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Figure 3. Mean scores for nurse EOC. The meta-analysis was conducted using random-effects model. Scores after
the last patient completed the study at a site. N 5 number of nurses; n 5 number of nurses completing each item.
Items 1 to 20, higher scores indicate more difficulty caring for patients using the delivery system (0 5 not at all to
5 5 a very great deal). Items 21 and 22, higher scores indicate less satisfaction with the delivery system (1 5
extremely satisfied to 65 extremely dissatisfied). EOC, ease of care; CI, confidence interval; ITS, iontophoretic trans-
dermal system; IV PCA, intravenous patient-controlled analgesia; SD, standard deviation; WMD, weighted mean dif-
ference.
6 PESTANO ET ALIV PCA was considered to have favored fentanyl
ITS over morphine IV PCA on that subscale or
vice versa. If the nurse had equal mean scores for
both treatment groups, they were considered
neutral toward either modality on that subscale.
For continuous variables, the weighted mean differ-
ence (WMD) between treatments was calculated.
For dichotomous variables, odds ratios indicating
the probability of the outcome to occur for a patient
receiving fentanyl ITS vs morphine IV PCA were
calculated. Statistical tests were performed at the.05 significance level, with no multiplicity adjust-
ments. Ninety-five percent confidence intervals
were provided for all parameters.Results
Across all three studies, the mean age of patients
ranged from 50.3 to 62.8 for the fentanyl ITS and
morphine IV PCA treatment groups with most be-
ing female (Table 1). Nurse EOC analyses were
based on responses to questionnaires from 848
COMPARISON OF FENTANYL ITS VS MORPHINE IV PCA 7(fentanyl ITS) and 761 (morphine IV PCA) nurses;
nurses provided care for patients from either one
or both treatment groups.
Nurse EOC
MEAN SCORE COMPARISONS. There was a sta-
tistically significant benefit in favor of fentanyl
ITS over morphine IV PCA in terms of the nurses’
overall EOC scores (WMD 5 20.57, P , .0001;
Figure 3). In addition, there was a statistically
significant benefit in each of the subscales favor-
ing fentanyl ITS over morphine IV PCA includingFigure 4. Analysis of EOC from nurses by item (mean sco
effects model. Scores after the last patient completed the s
nurses completing each item. Items 1 to 20, higher scores
delivery system (05 not at all to 5 5 a very great deal). Ite
with the delivery system (1 5 extremely satisfied to 6 5
dence interval; ITS, iontophoretic transdermal system;
WMD, weighted mean difference.time efficiency (WMD 5 20.58, P , .0001),
convenience (WMD 5 20.57, P , .0001), and
satisfaction (WMD 5 20.47, P , .0001)
(Figure 3). For most of the individual items in the
nurse EOC, there was a statistically significant
advantage for fentanyl ITS over morphine IV PCA
(Figure 4).
For 20 of the 22 items in the nurse EOC, there
was a statistically significant benefit for fentanyl
ITS over morphine IV PCA. Of the two remaining
items, there was a numerical, but not statistical,
benefit in favor of fentanyl ITS over morphine IVre). The meta-analysis was conducted using random-
tudy at a site. N 5 number of nurses; n 5 number of
indicate more difficulty caring for patients using the
ms 21 and 22, higher scores indicate less satisfaction
extremely dissatisfied). EOC, ease of care; CI, confi-
IV PCA, intravenous patient-controlled analgesia;
8 PESTANO ET ALPCA. The two items were the following: item 9 in
the time-efficiency subscale (determining
amount of medication provided to the subject)
and item 19 in the convenience subscale (deter-
mining amount of medication provided to the
subject). The percentages of nurses who re-
ported the most positive response for time-
efficiency items (ie, not at all time consuming),
convenience (ie, not at all bothersome), and
satisfaction (ie, extremely satisfied) was also
evaluated (Figure 5). For most items (18 of 22),
nurses responded with the most positive
response statistically significantly more
frequently for fentanyl ITS compared with
morphine IV PCA.Figure 5. Percentages of nurses who reported the most p
consuming), convenience (ie, not at all bothersome), and sati
conducted using random-effects model. Last nonmissing ass
during the study. Items 1 to 20, higher scores indicate more
(0 5 not at all to 5 5 a very great deal). Items 21 and 22, hi
system (15 extremely satisfied to 65 extremely dissatisfied
phoretic transdermal system; IV, intravenous; OR, odds ratioResponder Data
A nurse responder for the overall EOC was defined
as a nurse who responded with one of the three
most positive choices on all time-efficiency and
convenience items when at least 40% of items
are responded to. A nurse responder for time effi-
ciency and convenience was defined as a nurse
who responded with one of the three most posi-
tive choices for all items in each subscale if at least
40% of items are responded to for that subscale. A
nurse responder for satisfaction was defined as a
nurse who responded with one of the two most
positive choices for both satisfaction items in
each subscale if at least 50% of items are responded
to for that subscale.ositive response for time efficiency (ie, not at all time
sfaction (ie, extremely satisfied). The meta-analysis was
essment was used if a nurse had multiple assessments
difficulty caring for patients using the delivery system
gher scores indicate less satisfaction with the delivery
). EOC, ease of care; CI, confidence interval; ITS, ionto-
; PCA, patient-controlled analgesia.
COMPARISON OF FENTANYL ITS VS MORPHINE IV PCA 9There was a statistically significantly larger propor-
tion of nurses who were considered responders
for fentanyl ITS compared with morphine IV PCA
on the overall EOC (79.2% [556 of 702] vs 53.9%
[370 of 686], respectively; P , .0001), time-
efficiency subscale (81.2% [575 of 708] vs 57.0%
[393 of 690], respectively; P , .0001), conve-
nience subscale (85.3% [602 of 706] vs 64.0%
[439 of 686], respectively; P, .0001), and satisfac-
tion subscale (64.2% [537 of 837] vs 36.5% [256 of
756], respectively; P , .0001) (Figure 6).Responses of Nurses Who Evaluated Both
Fentanyl ITS and Morphine IV PCA
There was a statistically significantly larger propor-
tion of nurses who had experience with both sys-
tems and favored fentanyl ITS compared with
morphine IV PCA on the overall EOC (78% [318
of 406] vs 18% [73 of 406], respectively; P ,
.001), time-efficiency subscale (76% [315 of 406]
vs 17% [70 of 412], respectively; P, .001), conve-
nience subscale (72% [300 of 414] vs 16.0% [66 of
414], respectively; P , .0001), and satisfaction
subscale (55% [260 of 476] vs 17% [81 of 476],
respectively; P , .0001) (Figure 7).Figure 6. Nurse responders for overall, time efficiency, co
ducted using random-effects model. Last nonmissing assessm
the study. Overall EOC: A nurse responder for the overall EOC
three most positive choices of all time-efficiency and conven
Time efficiency and convenience: A nurse responder for time
responded with one of the three most positive choices for a
sponded to for that subscale. Satisfaction: A nurse responder
with one of the two most positive choices for both satisfac
responded to for this subscale. CI, confidence interval; ITS, i
patient-controlled analgesia; OR, odds ratio.Discussion
Findings from this meta-analysis indicate that fenta-
nyl ITS was preferred over morphine IV PCA in
terms of EOC from the nurses’ perspective. We
believe that this report represents the first meta-
analysis conducted that evaluated the nurses’
EOC using the nurse EOC questionnaire, a vali-
dated tool in postoperative pain management.22
In this meta-analysis, it was very clear that nurses
felt that there was greater time efficiency and con-
venience seen with fentanyl ITS vs morphine IV
PCA (as seen in looking at mean values of the sub-
scales, nurse responders, and proportion of nurses
who favored fentanyl ITS over morphine IV PCA).
This should translate into more time for direct pa-
tient care by nurses on surgical units. In addition,
nurses had a greater satisfaction level with fentanyl
ITS vs morphine IV PCA (as seen in looking at
mean values of the subscales, nurse responders,
and proportion of nurses who favored fentanyl
ITS over morphine IV PCA).
It is important to note that for the items related to
determining the amount ofmedication provided tonvenience, and satisfaction. The meta-analysis was con-
ent was used if a nurse hadmultiple assessments during
was defined as a nurse who respondedwith one of the
ience items when at least 40% of items are responded.
efficiency and conveniencewas defined as a nursewho
ll items in each subscale if at least 40% of items are re-
for satisfaction was defined as a nurse who responded
tion items in each subscale if at least 50% of items are
ontophoretic transdermal system; IV PCA, intravenous
Figure 7. Percentages of nurses’ responses that favored each PCA modality. (A) Overall. (B) Time efficiency. (C)
Convenience. (D) Satisfaction. Percentages of nurses’ responses that favored each PCAmodality (among nurses who
treated patients using both modalities). A nurse who had a lower mean score on a given subscale for patients who
received fentanyl ITS compared with patients who received morphine IV PCA was considered to have favored fen-
tanyl ITS over morphine IV PCA on that subscale and vice versa; if a nurse had equal mean scores for both treatment
groups, he or she was considered to have been neutral toward either modality on that subscale. *P, .001; P values
were calculated to determine the significance of the difference favoring fentanyl ITS over morphine IV PCAusing the
Fisher exact test. ITS, iontophoretic transdermal system; IV PCA, intravenous patient-controlled analgesia. This
figure is available in color online at www.jopan.org.
10 PESTANO ET ALthe subject, numerically favored fentanyl ITS over
morphine IV PCA. However, since the time that
the studies were completed and before Food and
Drug Administration and European Medicines
Evaluation Agency approval in 2015, there has
been a change in the design of the fentanyl ITS
drug delivery system to make accounting for the
number of doses administered easier for the nurse.
The new fentanyl ITS was enhanced to include a
numeric display of the number of doses delivered,
which will make it easier for the nursing staff to
calculate dosages.
Patient mobility is essential to postoperative re-
covery and is one of the most important factorsfor preventing complications after major sur-
gery.27 The hazards of immobility include pneu-
monia, pulmonary embolus, pulmonary
compromise, deep vein thrombosis, and urinary
tract infections.27 In fact, early postoperative pa-
tient mobility is a key in most successful
enhanced recovery after surgery programs.28,29
In both the time-efficiency and convenience sub-
scales, the items related to positioning, moving,
or transferring the subject with the device signif-
icantly favored fentanyl ITS over morphine IV
PCA. Fentanyl ITS may increase patients’
mobility because no IVor epidural lines or equip-
ment such as pumps and poles are needed for
analgesia.
COMPARISON OF FENTANYL ITS VS MORPHINE IV PCA 11In this meta-analysis, there was a significant advan-
tage for fentanyl ITS over morphine IV PCA in
terms of maintaining device function and changing
or adjusting the device because of malfunction or
dosing changes from both a time-efficiency and
convenient standpoint. Similarly, in a study that
compared analgesic gaps with fentanyl ITS and
morphine IV PCA in patients being treated for
postoperative pain, there was a significantly lower
incidence of analgesic gaps per 100 patients
compared with morphine IV PCA.30 In the same
study, there were numerical advantages for fenta-
nyl ITS over morphine IV PCA in terms of lower
median total analgesic gap time and lower median
total system-related event resolution time.
TwoDelphi panels of nurses (onewith clinical trial
nurses and the other with routine practice nurses)
conducted in the United States have estimated the
nursing time required with the fentanyl ITS and IV
PCA for postoperative pain management.14 Ac-
cording to both panels, using the fentanyl ITS
should require less nursing time with fewer tasks
than using IV PCA. This result was duplicated by
a Delphi panel of nurses and anesthesiologists in
Europe.13 The results of the convenience subscale
and items suggest that nurses should find that fen-
tanyl ITS offers advantages over morphine IV PCA
that should translate into time savings in terms of
PCA management that will allow more time for
direct nursing care.Limitations
This meta-analysis is limited in that only three tri-
als comparing fentanyl ITS and morphine IV PCA
for the nurse EOC were available for inclusion.
Another potential limitation of this meta-
analysis is that all the studies were conducted us-
ing an open-label design. However, an open-label
design is the only method that can adequately
capture and differentiate this type of EOC ques-
tionnaire as it is based on actual experience. If
it had been blinded and both the ITS (placebo
or active) and IV PCA (placebo or active) it
would have been impossible to get accurate
EOC responses.
Conclusions
Results of this meta-analysis demonstrate that in
terms of EOC from the nurses’ perspective fenta-
nyl ITS is preferred over morphine IV PCA. The re-
sults of this meta-analysis are consistent with the
previously published pooled analysis.23 The
strength of the currentmeta-analysis is that individ-
ual studies are weighted first and then combined,
which should avoid the problems sometimes
seen with simple pooling.
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